Related Experiment Video
Updated: May 10, 2025
08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
10.8K
Research progress on N6-methyladenosine and non-coding RNA in multiple myeloma
Xiaoqi Sun1, Yongming Zhou1, Wenwei Zhu1
1Department of Hematology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
Discover Oncology
|April 25, 2025
Summary
N6-methyladenosine (m6A) and non-coding RNA (ncRNA) are crucial in multiple myeloma (MM) progression and drug resistance. Understanding their roles is vital for improving MM diagnosis, treatment, and patient survival outcomes.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- N6-methyladenosine (m6A) and non-coding RNAs (ncRNAs) are key epigenetic regulators.
- These molecules are implicated in various cellular processes relevant to cancer development.
Purpose of the Study:
- To elucidate the significant roles of m6A and ncRNA in multiple myeloma (MM).
- To highlight their impact on MM cell behavior and patient prognosis.
Main Methods:
- Literature review and analysis of existing research on m6A and ncRNA in MM.
- Examination of their influence on MM cell stemness, proliferation, apoptosis, migration, and invasion.
Main Results:
- m6A and ncRNA significantly influence MM cell stemness, growth, and apoptosis.
- They are involved in MM proliferation, migration, invasion, and drug resistance.
- These molecules serve as prognostic factors for poor MM survival.
Conclusions:
- m6A and ncRNA are critical players in the pathogenesis and progression of multiple myeloma.
- Further research into their mechanisms is essential for advancing MM diagnosis, treatment strategies, and prognostic accuracy.
Related Concept Videos
02:55The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
01:22MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
01:53RNA Stability
33.0K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.0K
02:23RNA Editing
8.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.8K